Chemours (NYSE:CC – Get Free Report) will be releasing its earnings data after the market closes on Tuesday, April 30th. Analysts expect Chemours to post earnings of $0.25 per share for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link.
Chemours (NYSE:CC – Get Free Report) last posted its quarterly earnings data on Wednesday, March 27th. The specialty chemicals company reported $0.31 earnings per share for the quarter, beating analysts’ consensus estimates of $0.29 by $0.02. The company had revenue of $1.36 billion during the quarter, compared to analysts’ expectations of $1.37 billion. Chemours had a negative net margin of 3.80% and a positive return on equity of 51.73%. On average, analysts expect Chemours to post $2 EPS for the current fiscal year and $3 EPS for the next fiscal year.
Chemours Stock Performance
NYSE:CC opened at $27.32 on Friday. The company has a debt-to-equity ratio of 5.40, a current ratio of 1.54 and a quick ratio of 1.00. The firm has a 50-day moving average of $26.70 and a two-hundred day moving average of $27.82. The stock has a market cap of $4.07 billion, a P/E ratio of -17.63 and a beta of 2.00. Chemours has a 1-year low of $15.10 and a 1-year high of $39.05.
Chemours Announces Dividend
Wall Street Analyst Weigh In
A number of equities research analysts have recently issued reports on CC shares. UBS Group upped their target price on shares of Chemours from $21.00 to $28.00 and gave the company a “neutral” rating in a research note on Tuesday, April 2nd. BMO Capital Markets upgraded shares of Chemours from an “underperform” rating to an “outperform” rating and upped their target price for the company from $19.00 to $34.00 in a research note on Tuesday, April 9th. Finally, Barclays cut their target price on shares of Chemours from $32.00 to $30.00 and set an “equal weight” rating on the stock in a research note on Tuesday, April 2nd. Seven investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $30.89.
View Our Latest Report on Chemours
Chemours Company Profile
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.
Read More
- Five stocks we like better than Chemours
- Ride Out The Recession With These Dividend Kings
- MarketBeat Week in Review – 4/22 – 4/26
- How to Use the MarketBeat Excel Dividend Calculator
- 3 Stocks Leading the U.S. Agriculture Comeback
- 5 Top Rated Dividend Stocks to Consider
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.